MetaSight Diagnostics

About MetaSight Diagnostics

MetaSight pioneers the development of accurate, affordable, and accessible disease diagnostics and monitoring through advanced blood testing, designed for high-volume population-scale screening. They utilize a robust discovery platform integrating proprietary high-throughput mass-spectrometry multi-OMICs technology, population-scale serum sample collection, and access to electronic health records.

Products & Services

Multi-OMIC Testing:Diagnostics and monitoring solutions using advanced blood testing for population-scale screening.

MASH-Fibrosis Diagnostics:Specific diagnostic solution focused on MASH-Fibrosis.

Colorectal Cancer Diagnostics:Diagnostic solution targeting colorectal cancer detection.

Specialties

Disease Diagnostics Blood Testing Multi-OMICs Technology Population-Scale Screening

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 8000000 MR: - FA: 8 million FAN: 8000000	D: 2024-11-13 FD: 2024-11-13	5 investors

Series A Latest

2024-11-13

$8.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tomer Shlomi

Founder & CEO

LinkedIn (Pro only)

S

Shira Shaham-Niv

CSO

LinkedIn (Pro only)

B

Boris Sarvin

VP Technologies

LinkedIn (Pro only)

N

Noa Avni

VP Product

A

Avi Shoshan

VP Data Science

M

Michele Pedrocchi

Former Global Head of Strategy and Business Development for Diagnostics

View 6 more team members with Pro

Unlock Full Team Directory

Recent News